The Master of Pharmacy (International) is an accredited three-year graduate-entry degree leading to eligibility for registration as a pharmacist. The course is an Australian first, extending the Master of Pharmacy (C04252) program to include a one-year overseas clinical placement. This allows students to expand their knowledge even further, gaining practice-based experience of pharmacy in a global context and an understanding of the international factors that influence pharmacy practice and healthcare provision. Overseas clinical placements include those in Canada, Germany or the United Kingdom. Language and culture subjects cater to both beginners and students with prior language knowledge. The course is innovative and practice-based in approach, building on students' strong scientific foundation to provide specialist, comprehensive knowledge relevant to contemporary pharmacy practice. In addition to the pharmaceutical sciences, this includes professional pharmacy services, integrated therapeutics and the unique capstone subject, 96014 Molecule to Market, supported by industry leader Adjunct Professor John Montgomery. Two elective subjects provide students with the opportunity to individualise their studies with their choice of any available postgraduate subject offered at UTS.
Developed by leading pharmacy academics and an expert educational designer, the course's subject matter is delivered in an integrated, student-focused manner, making use of cutting-edge technologies and strong links with the pharmacy profession. Expert guest lecturers and practitioner teachers are utilised throughout the course to ensure relevance and real-world application of content.
In addition to the one-year international placement, students undertake clinical practice in a wide variety of settings sourced by UTS throughout the degree. This includes a guaranteed hospital pharmacy placement for eligible students. On-campus learning takes place in the Graduate School of Health's state-of-the-art education and research facility, which opened in 2019.